Weight Loss Surgery for Mild to Moderate Obesity: A Systematic Review and Economic Evaluation
A systematic review and economic evaluation was commissioned to determine the effectiveness and cost-effectiveness of bariatric surgery for mild [class I, body mass index (BMI) 30 to 34.99] or moderate (class II, BMI 35 to 39.99) obesity.
We searched 17 electronic resources (to February 2010) and other sources. Studies meeting predefined criteria were identified, data-extracted and assessed for risk of bias using standard methodology. A model was developed to estimate cost-effectiveness.
Two RCTs were included. Evidence from both indicated a statistically significant benefit from laparoscopic adjustable banding (LAGB) compared to a non-surgical comparator for weight loss and in obesity-related comorbidity. Both interventions were associated with adverse events. LAGB costs more than non-surgical management. For people with class I or II obesity and type 2 diabetes (T2D), the incremental cost-effectiveness ratio (ICER) at 2 years is £20,159, reducing to £4,969 at 5 years and £1,634 at 20 years. Resolution of T2D makes the greatest contribution to this reduction. In people with class I obesity, the ICER is £63,156 at 2 years, £17,158 at 5 years, and £13,701 at 20 years. Cost-effectiveness results are particularly sensitive to utility gain from reduction in BMI, factors associated with poorer surgical performance and diabetes health state costs.
Bariatric surgery appears to be a clinically effective and cost-effective intervention for people with class I or II obesity who also have T2D but is less likely to be cost-effective for people with class I obesity.
KeywordsBariatric surgery Obesity Diabetes mellitus Systematic review Cost-effectiveness
Conflict of Interest
All contributing authors declare that they have no conflicts of interest.
- 1.Ruhm CJ. Current and future prevalence of obesity and severe obesity in the United States. Working Paper 13181. 2007. National Bureau of Economic Research.Google Scholar
- 2.McPherson K, Marsh T, Brown M. Foresight. Tackling obesities: future choices—modelling future trends in obesity and the impact on health. 2nd Edition; 2007.Google Scholar
- 3.Sassi F, Devaux M, Cecchini M, et al. The obesity epidemic: analysis of past and projected future trends in selected OECD countries. OECD Health Working Papers, No. 45. 2009. OECD Publishing.Google Scholar
- 5.Report by the comptroller and auditor general. Tackling obesity in England. 1–65. London: The Stationery Office; 2001.Google Scholar
- 6.Department of Health. Health risk and costs of obesity. 2007. http://www.dh.gov.uk/en/Publichealth/Healthimprovement/Obesity/DH_4133949. Accessed 3 March 2009.
- 7.The Information Centre, Yorkshire & Humber Public Health Observatory. Prescribing for Diabetes in England. An analysis of volume, expenditure and trends; 2007.Google Scholar
- 14.Depaula AL, Macedo AL, Mota BR et al. Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21–29. Surg Endosc. 2008.Google Scholar
- 22.Colquitt J, Clegg A, Loveman E, et al. Surgery for morbid obesity. Cochrane Database Syst Rev. 2005; Issue 4. Art. No.:CD003641. doi: 10.1002/14651858.CD003641.pub2.
- 23.Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1–357. iii.Google Scholar
- 24.Cochrane Collaboration. Assessing risk of bias in included studies. In: Higgins J, Altman D, editors. Cochrane handbook for systematic reviews of interventions, Preliminary Draft, 3 December 2007 edition; 2007.Google Scholar
- 26.O’Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial.[see comment][summary for patients in Ann Intern Med. 2006 May 2;144(9):I12; PMID: 16670127]. Ann Intern Med. 2006;144:625–33.PubMedGoogle Scholar
- 29.Andersen KM, Odell PM, Wilson WF, et al. Cardiovascular disease risk profiles. Am Hear J. 1991;121:2–293.Google Scholar
- 32.Department of Health. NHS Reference Costs 2006–2007. Department of Health; 2008. 27-2-0008.Google Scholar
- 33.Curtis L. Unit costs of Health and Social Care, PSSRU, University of Kent; 2007.Google Scholar
- 34.Ward S, Lloyd Jones M, Pandor A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess. 2007;11.Google Scholar